Dr. Argye Hillis is a professor of Neurology, with joint faculty appointments in Physical Medicine and Rehabilitation and in Cognitive Science. She is also the Sheikh Khalifa Stroke Institute Professor of Acute Stroke Diagnoses and Management. Prior to medical training and neurology residency, Dr. Hillis worked as a speech-language pathologist, and conducted clinical research focusing on understanding and treating aphasia and hemispatial neglect. She has brought these areas of experience to impact on her clinical research in neurology, which involves cognitive and neuroimaging studies of aphasia and hemispatial neglect due to acute stroke and focal dementias. She has published extensively on these topics in journals and textbooks. Dr. Hillis is Associate Editor of Stroke and has served as Associate editor of Brain, Annals of Neurology, Aphasiology, American Journal of Speech-Language Pathology, Neurocase, Cognitive Neuropsychology, and Language and Cognitive Processes and served as co-Editor and Chief of Behavioral Neurology. Dr. Hillis serves as the Executive Vice Chair of the Department of Neurology and the Director of the Cerebrovascular Division of Neurology at Johns Hopkins. Dr. Hillis is rated as an Elite provider by MediFind in the treatment of Frontotemporal Dementia. Her top areas of expertise are Primary Progressive Aphasia, Stroke, Frontotemporal Dementia, Thrombectomy, and Gastrostomy.

Bryan Traynor is a Neurologist in Baltimore, Maryland. Dr. Traynor is rated as a Distinguished provider by MediFind in the treatment of Frontotemporal Dementia. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Frontotemporal Dementia, Dementia, and Thymectomy.

Harvey Pats is a Neurologist in Forest Hill, Maryland. Dr. Pats is rated as a Distinguished provider by MediFind in the treatment of Frontotemporal Dementia. His top areas of expertise are Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Primary Progressive Aphasia, Frontotemporal Dementia, and Thoracic Outlet Syndrome. Dr. Pats is currently accepting new patients.

Dr. Scholz is a neurologist and geneticist specializing in neurodegenerative disorders such as Parkinson's disease, atypical parkinsonism and dementia syndromes. She received her medical degree from the Medical University Innsbruck, Austria. Following graduation, she was a postdoctoral fellow at the National Institutes of Health under the supervision of Drs. Andrew Singleton and John Hardy. She obtained a Ph.D. in neurogenomics from the University College London, UK in 2010. She then moved to Baltimore to complete her neurology residency training at Johns Hopkins. In 2015 Dr. Scholz received the McFarland Transition to Independence Award for Neurologist-Scientists. She is Lasker Clinical Research Scholar at the National Institute of Neurological Disorders and Stroke focusing on genetic causes of neurodegenerative syndromes, and an adjunct faculty member at Johns Hopkins' department of neurology. Dr. Scholz is rated as a Distinguished provider by MediFind in the treatment of Frontotemporal Dementia. Her top areas of expertise are Lewy Body Dementia (LBD), Multiple System Atrophy, Movement Disorders, and Parkinson's Disease.

Dr. Alexander Pantelyat cares for patients with movement disorders such as Parkinson's disease and related syndromes, essential tremor, dystonia, chorea and normal pressure hydrocephalus. He also provides botulinum toxin injections for movement disorders and is involved in deep brain stimulation programming and intraoperative neurophysiological monitoring.His research explores atypical parkinsonian disorders, such as dementia with Lewy bodies, progressive supranuclear palsy, corticobasal syndrome/degeneration and multiple system atrophy; cognitive aspects of movement disorders; and music-based rehabilitation of neurodegenerative diseases.Dr. Pantelyat earned his medical degree from Temple University School of Medicine in Philadelphia, where he was elected a member of the Alpha Omega Alpha Honor Medical Society and received the Matthew T. Moore Prize in Neurology. He completed his residency training in Neurology ​at the University of Pennsylvania in Philadelphia, and a fellowship in movement disorders at the University of Pennsylvania/Philadelphia VA Medical Center. As part of his fellowship, Dr. Pantelyat also completed the Clinical Research Certificate Program at the Center for Clinical Epidemiology and Biostatistics. He is a 2013 American Academy of Neurology Palatucci Advocacy Leader and grant recipient. Dr. Pantelyat is rated as an Advanced provider by MediFind in the treatment of Frontotemporal Dementia. His top areas of expertise are Progressive Supranuclear Palsy, Progressive Supranuclear Palsy Atypical, Supranuclear Ophthalmoplegia, and Corticobasal Degeneration.

Dr. Halima Amjad is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. Her clinical expertise in geriatric medicine focuses on the diagnosis, treatment, and care for individuals living with dementia. Dr. Amjad earned her M.D. and Master’s of Public Health from Drexel University. She completed her residency and chief residency in internal medicine at Yale-New Haven Hospital and a fellowship in geriatric medicine and gerontology at Johns Hopkins University School of Medicine. She joined the faculty of Johns Hopkins in 2016. She completed a PhD in Clinical Investigation at the Johns Hopkins University Bloomberg School of Public Health in 2022. She conducts health services research focuses on informing and improving the care of older adults with dementia with research into underdiagnosis, hospitalization, and primary care in dementia. Recent News Articles and Media Coverage Doyle K. Older adults with probable dementia often take part in unsafe activities. Reuters, June 3, 2016 Many people who have dementia don’t know it. Here’s who’s most at risk, The Philadelphia Inquirer, July 23, 2018 With cognitive impairment, older adults struggle with — and face risks from — smartphones, computers. Washington Post, (October 13, 2019). Dr. Amjad is rated as an Advanced provider by MediFind in the treatment of Frontotemporal Dementia. Her top areas of expertise are Dementia, Alzheimer's Disease, Cerebellar Degeneration, and Frontotemporal Dementia.

Robert Monteleone is a primary care provider, practicing in Family Medicine in Elkton, Maryland. Dr. Monteleone is rated as an Experienced provider by MediFind in the treatment of Frontotemporal Dementia. His top areas of expertise are Type 2 Diabetes (T2D), Constrictive Pericarditis, Nasopharyngeal Carcinoma, and Maturity Onset Diabetes of the Young. Dr. Monteleone is currently accepting new patients.

Mary Floeter is a Neurologist in Bethesda, Maryland. Dr. Floeter is rated as an Advanced provider by MediFind in the treatment of Frontotemporal Dementia. Her top areas of expertise are Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Frontotemporal Dementia, and Pseudobulbar Affect.

Dimitrios Kapogiannis is a Neurologist in Baltimore, Maryland. Dr. Kapogiannis is rated as an Advanced provider by MediFind in the treatment of Frontotemporal Dementia. His top areas of expertise are Alzheimer's Disease, Dementia, Developmental Dysphasia Familial, and Memory Loss.

Robert Paschall is a Neurologist in Salisbury, Maryland. Dr. Paschall is rated as an Advanced provider by MediFind in the treatment of Frontotemporal Dementia. His top areas of expertise are Epilepsy, Stroke, Memory Loss, Seizures, and Gastrostomy. Dr. Paschall is currently accepting new patients.

Mfon Umoh, M.D., Ph.D., is an Assistant Professor in the Division of Geriatric Medicine and Gerontology. Her clinical expertise in geriatric medicine focuses on the diagnosis, treatment, and care for individuals living with dementia and older adults experiencing cognitive decline. Dr. Umoh earned her MD and PhD in Neuroscience from Emory University. She completed her residency in Internal Medicine at Johns Hopkins Bayview Medical Center and her fellowship in Geriatric Medicine at Johns Hopkins University School of Medicine. Dr. Umoh is a K12 Clinical Research Scholar, and a Sarah Miller Coulson Center for Innovative Medicine Human Aging Project and Next Generation Scholar. Her clinical work, research, and teaching centers on improving cognitive outcomes for older adults. Her research focuses on examining biological and social contextual factors that contribute to poor cognitive outcomes for older adults. The goal of her work is to inform clinical care and interventions focused on modifiable risk factors associated with cognitive decline and dementia. Dr. Umoh is rated as an Experienced provider by MediFind in the treatment of Frontotemporal Dementia. Her top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Dementia, and Frontotemporal Dementia.

Milap Nowrangi, M.D., MS, is an assistant professor of psychiatry and behavioral sciences at The Johns Hopkins University School of Medicine. Dr. Nowrangi specializes in the diagnosis and treatment of age-related cognitive disorders, including Alzheimer's Disease and related dementias. He also is interested in the treatment or management of behavioral and cognitive sequelae of neurological diseases, including those caused by traumatic brain injury, stroke, epilepsy or toxic exposures. Dr. Nowrangi is rated as an Experienced provider by MediFind in the treatment of Frontotemporal Dementia. His top areas of expertise are Alzheimer's Disease, Dementia, Bipolar Disorder (BPD), and Neuronal Intranuclear Inclusion Disease (NIID).

Dagmara Pychynski is a Neurologist in Elkton, Maryland. Dr. Pychynski has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of Frontotemporal Dementia. Her top areas of expertise are Generalized Tonic-Clonic Seizure, Seizures, Peripheral Neuropathy, and Memory Loss.

Dr. Esther Oh is a Professor of Medicine, Psychiatry and Behavioral Sciences and Pathology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise is in evaluation and management of memory disorders. She has an extensive experience in evaluating memory disorders in older adults with multiple chronic diseases, and takes and integrative approach in the treatment of memory disorders. Dr. Oh also serves as the co-director of the Johns Hopkins Memory and Alzheimer’s Treatment Center. Dr. Oh earned her M.D. from the UHS/Chicago Medical School. She completed her residency in internal medicine at the University of Illinois at Chicago where she was a chief resident. She completed a fellowship in geriatric medicine and gerontology at Johns Hopkins University School of Medicine, and received her Ph.D. from the Johns Hopkins Bloomberg School of Public Health. Dr. Oh has received numerous awards including the Merck New Investigator Award, AFAR New Investigator Award in Alzheimer’s disease, and the Johns Hopkins Clinical Research Scholars Award. She is also a recipient of several major grants from the National Institute on Aging (NIA). She has also been honored for her teaching by Excellence in Teaching Award in the Division of Geriatric Medicine and Gerontology in 2013 and 2017. Dr. Oh’s research is primarily focused on Alzheimer’s disease and related disorders. Her current projects include: development of biomarkers for detecting early stages of Alzheimer’s disease; understanding the interrelationship between delirium and Alzheimer’s disease; cognitive changes after surgery; and understanding the role of sensory problems (hearing and vestibular function) in Alzheimer’s disease. Dr. Oh is rated as an Experienced provider by MediFind in the treatment of Frontotemporal Dementia. Her top areas of expertise are Delirium, Alzheimer's Disease, Dementia, Deep Brain Stimulation, and Liver Transplant.

Nicholas Maragakis treats patients with motor neuron diseases, such as amyotrophic lateral sclerosis (ALS). This care is coordinated with the Johns Hopkins Center for ALS Specialty Care, a multidisciplinary clinic with expertise in treating patients with ALS and providing support to their caregivers. He serves as medical director of the ALS Clinical Trials Unit, an extension of the multidisciplinary clinic that seeks to facilitate opportunities for patients with ALS to participate in clinical trials that could advance the treatment of this disease. Dr. Maragakis is interested in the basic science of understanding neurodegenerative diseases, as well as the translational potential of therapeutic compounds developed in the laboratory. His fundamental research interest is in using stem cells — more specifically, stem cell-derived motor neurons and glia — for understanding the development and propagation of ALS. His laboratory has been involved in creating and characterizing lines of stem cells from patients with ALS using induced pluripotent stem cell (iPSC) methodologies. The laboratory has a large library of iPSCs from patients with familial ALS and from patients with sporadic ALS. The utilization of this library of iPSCs has facilitated the development of a spinal cord-specific iPSC-astrocyte/motor neuron co-culture system, which has been leveraged for the development of assays that can be used for both the basic understanding of ALS astrocyte and motor neuron biology as well as, eventually, drug screening for ALS therapeutics. His laboratory has taken its long-standing interests in astrocyte biology, as it relates to ALS, to develop a program that investigates astrocyte-specific mechanisms as contributors to the progression (both temporally and anatomically) of disease in ALS. In this vein, there is an interest in astrocytic glutamate transporters and, more recently, astrocyte hemichannels and gap junctions. Dr. Maragakis is rated as an Experienced provider by MediFind in the treatment of Frontotemporal Dementia. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, 15q11.2 Microdeletion, and Spinal Muscular Atrophy (SMA).

Shakunmala Gupta is a primary care provider, practicing in Hospital Medicine in Columbia, Maryland. Dr. Gupta is rated as an Experienced provider by MediFind in the treatment of Frontotemporal Dementia. Her top areas of expertise are Dementia, Movement Disorders, Parkinson's Disease, and Anemia.

Dr. Chua is an assistant professor in the Department of Neurology and Division of Movement Disorders at Johns Hopkins. He received his training at the University of Michigan, where he obtained medical and graduate degrees, then completed a residency in neurology and a combined clinical/research fellowship in movement disorders and neurodegeneration. Dr. Chua’s primary research interests are in neurodegenerative disease with a special focus on autophagy — an essential housekeeping process in cells that is particularly important for the health of neurons. Autophagy may provide a way to break down the buildup of toxic proteins found in neurodegenerative diseases, thereby forming the basis of new treatment strategies for these incurable conditions. He has received multiple research grants to support his work, including from the National Institute of Neurological Disorders and Stroke and the American Academy of Neurology (AAN). He is the primary author and co-author of multiple peer-reviewed scientific publications and online learning modules as part of the AAN. Dr. Chua is a contributing author to The Little Black Book of Neurology by Osama Zaidat, Alan Lerner and J. Douglas Miles, and he has been a peer reviewer for the scientific journals Autophagy, eLife and Neurobiology of Disease. He currently serves on the scientific advisory board for the Don't Forget Morgan Foundation, a private organization supporting research and outreach regarding the disease beta-propeller protein-associated neurodegeneration (BPAN). For more information about the Chua Lab, please visit https://chualab.jhmi.edu. Dr. Chua is rated as an Experienced provider by MediFind in the treatment of Frontotemporal Dementia. His top areas of expertise are Primary Lateral Sclerosis, Parkinson's Disease, Movement Disorders, and Camptocormism.

Dr. Ankur Butala specializes in the care of persons with complex neuropsychiatric conditions, including persons with advanced Parkinson Disease or other movement or neurodegenerative disorders. Upon graduating from a selective Physician-Scientist program at Albany Medical College, he joined the University of Massachusetts in an uncommon residency in both Neurology and Psychiatry. Dual-trained neuropsychiatrists such as Dr. Butala have experience with: Parkinson Disease and atypical Parkinsonism, Huntington Disease, Ataxia, Dystonia, early-onset dementia, traumatic brain injury and chronic traumatic encephalopathy, autism spectrum disorders, medication refractory mood and psychotic disorders, epilepsy and functional neurological disorders. In residency, he developed an interest in circuit models of brain function and how non-pharmacological approaches such as Neuromodulation and brain stimulation may be used to address treatment-resistant conditions. Consequently, he joined Johns Hopkins University School of Medicine as a Clinical and Research Fellow from 2015 to 2018, where he developed a skill set including deep brain stimulation, non-invasive brain stimulation (tDCS), and measurement of eye movements. Currently, Dr. Butala's clinical and research interests are in diagnosing and managing persons with advanced Parkinson's Disease, movement disorders, and neuropsychiatric conditions using neuromodulation, cannabinoids, and entheogens. He has ongoing multidisciplinary collaborations with colleagues at the Whiting School of Engineering - Center of Speech & Language Processing in using Machine-Learning Models and Artificial Intelligence to improve the detection and diagnosis of Movement and Neuropsychiatric disorders. LinkedIn https://www.linkedin.com/in/ankurbutalamd Videos Neurology: Junior Faculty Spotlight. Dr. Butala is rated as an Experienced provider by MediFind in the treatment of Frontotemporal Dementia. His top areas of expertise are Parkinson's Disease, Corticobasal Degeneration, Movement Disorders, Drug Induced Dyskinesia, and Deep Brain Stimulation.

Dr. Jee Bang cares for patients with disorders of cognition and movement, such as Huntington disease, progressive supranuclear palsy, corticobasal degeneration, multiple system atrophy, dementia with Lewy bodies, frontotemporal dementia, and Alzheimer disease. Dr. Bang is rated as an Experienced provider by MediFind in the treatment of Frontotemporal Dementia. Her top areas of expertise are Huntington Disease, Mcleod Neuroacanthocytosis Syndrome, Supranuclear Ocular Palsy, and Progressive Supranuclear Palsy.

Feroz Padder is a Cardiologist and an Interventional Cardiologist in Laurel, Maryland. Dr. Padder is rated as an Experienced provider by MediFind in the treatment of Frontotemporal Dementia. His top areas of expertise are Heart Attack, Hypertensive Heart Disease, Atherosclerosis, and Coronary Heart Disease.